Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
Condition(s):Irritable Bowel SyndromeLast Updated:May 17, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Irritable Bowel SyndromeLast Updated:May 17, 2021Terminated
Condition(s):Atopic DermatitisLast Updated:November 4, 2022Completed
Condition(s):Irritable Bowel SyndromeLast Updated:October 12, 2022Terminated
Condition(s):Ulcerative ColitisLast Updated:December 21, 2022Completed
Condition(s):Ulcerative ColitisLast Updated:December 20, 2022Completed
Condition(s):Crohn’s Disease; Abdominal PainLast Updated:November 2, 2021Completed
Condition(s):Primary Biliary CholangitisLast Updated:March 24, 2022Terminated
Condition(s):Inflammatory Bowel Diseases; Skin Extra-intestinal ManifestationsLast Updated:December 31, 2020Terminated
Condition(s):Pyoderma GangrenosumLast Updated:June 11, 2021Terminated
Condition(s):Ulcerative ColitisLast Updated:November 26, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.